PDL BioPharma (PDLI) Terminates Interest in Pursuing Acquisition of Neos (NEOS)

February 20, 2018 7:05 AM

PDL BioPharma, Inc. (NASDAQ: PDLI) today officially announced it will no longer pursue its proposed acquisition of Neos Therapeutics, Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found